Cargando…

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma

Esophageal carcinoma (EC) is a common malignant disease worldwide, especially in China. There is currently no specific blood test for detecting EC. Autoantibodies against tumor‐associated antigens (TAAbs) and microRNAs (miRNAs) are promising markers for cancer diagnosis and this study focuses on com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Guiying, Ye, Hua, Wang, Xiao, Li, Tiandong, Jiang, Di, Qiu, Cuipeng, Dai, Liping, Shi, Jianxiang, Wang, Kaijuan, Song, Chunhua, Wang, Peng, Zhang, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997060/
https://www.ncbi.nlm.nih.gov/pubmed/31856412
http://dx.doi.org/10.1002/cam4.2792
_version_ 1783493615092236288
author Sun, Guiying
Ye, Hua
Wang, Xiao
Li, Tiandong
Jiang, Di
Qiu, Cuipeng
Dai, Liping
Shi, Jianxiang
Wang, Kaijuan
Song, Chunhua
Wang, Peng
Zhang, Jianying
author_facet Sun, Guiying
Ye, Hua
Wang, Xiao
Li, Tiandong
Jiang, Di
Qiu, Cuipeng
Dai, Liping
Shi, Jianxiang
Wang, Kaijuan
Song, Chunhua
Wang, Peng
Zhang, Jianying
author_sort Sun, Guiying
collection PubMed
description Esophageal carcinoma (EC) is a common malignant disease worldwide, especially in China. There is currently no specific blood test for detecting EC. Autoantibodies against tumor‐associated antigens (TAAbs) and microRNAs (miRNAs) are promising markers for cancer diagnosis and this study focuses on combining TAAbs and miRNAs to evaluate the diagnostic value in esophageal squamous cell carcinoma (ESCC). The expression levels of seven TAAbs and five microRNAs in plasmas from 125 patients diagnosed with ESCC and 125 healthy individuals were detected by enzyme‐linked immunosorbent assay (ELISA) and reverse transcription quantitative‐polymerase chain reaction (RT‐qPCR), respectively. The receiver operating characteristic (ROC) analysis was applied to estimate the diagnostic value of these markers for distinguishing ESCC patients from normal individuals. Logistic regression analysis was performed to generate prediction model and calculate the probability of individuals being diagnosed with ESCC. Three panels were established including four TAAbs, three miRNAs, and three TAAbs combined with three miRNAs. The panel consisting of three TAAbs (HCCR, C‐myc, and MDM2) and three miRNAs (miR‐21, miR‐223, and miR‐375) attained great diagnostic value for ESCC, with an area under the receiver operating characteristic curve (AUC) of 0.89 (95% CI: 0.85‐0.93) with the sensitivity of 69%, the specificity of 90%, the PPV of 83%, the NPV of 79%, and the coincidence rate of 81%. The optimal panel of six‐member markers was able to effectively discriminate the patients with ESCC from normal individuals, especially for early esophageal squamous cell carcinoma.
format Online
Article
Text
id pubmed-6997060
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69970602020-02-05 Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma Sun, Guiying Ye, Hua Wang, Xiao Li, Tiandong Jiang, Di Qiu, Cuipeng Dai, Liping Shi, Jianxiang Wang, Kaijuan Song, Chunhua Wang, Peng Zhang, Jianying Cancer Med Cancer Biology Esophageal carcinoma (EC) is a common malignant disease worldwide, especially in China. There is currently no specific blood test for detecting EC. Autoantibodies against tumor‐associated antigens (TAAbs) and microRNAs (miRNAs) are promising markers for cancer diagnosis and this study focuses on combining TAAbs and miRNAs to evaluate the diagnostic value in esophageal squamous cell carcinoma (ESCC). The expression levels of seven TAAbs and five microRNAs in plasmas from 125 patients diagnosed with ESCC and 125 healthy individuals were detected by enzyme‐linked immunosorbent assay (ELISA) and reverse transcription quantitative‐polymerase chain reaction (RT‐qPCR), respectively. The receiver operating characteristic (ROC) analysis was applied to estimate the diagnostic value of these markers for distinguishing ESCC patients from normal individuals. Logistic regression analysis was performed to generate prediction model and calculate the probability of individuals being diagnosed with ESCC. Three panels were established including four TAAbs, three miRNAs, and three TAAbs combined with three miRNAs. The panel consisting of three TAAbs (HCCR, C‐myc, and MDM2) and three miRNAs (miR‐21, miR‐223, and miR‐375) attained great diagnostic value for ESCC, with an area under the receiver operating characteristic curve (AUC) of 0.89 (95% CI: 0.85‐0.93) with the sensitivity of 69%, the specificity of 90%, the PPV of 83%, the NPV of 79%, and the coincidence rate of 81%. The optimal panel of six‐member markers was able to effectively discriminate the patients with ESCC from normal individuals, especially for early esophageal squamous cell carcinoma. John Wiley and Sons Inc. 2019-12-19 /pmc/articles/PMC6997060/ /pubmed/31856412 http://dx.doi.org/10.1002/cam4.2792 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Sun, Guiying
Ye, Hua
Wang, Xiao
Li, Tiandong
Jiang, Di
Qiu, Cuipeng
Dai, Liping
Shi, Jianxiang
Wang, Kaijuan
Song, Chunhua
Wang, Peng
Zhang, Jianying
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title_full Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title_fullStr Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title_full_unstemmed Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title_short Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
title_sort autoantibodies against tumor‐associated antigens combined with micrornas in detecting esophageal squamous cell carcinoma
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997060/
https://www.ncbi.nlm.nih.gov/pubmed/31856412
http://dx.doi.org/10.1002/cam4.2792
work_keys_str_mv AT sunguiying autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT yehua autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT wangxiao autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT litiandong autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT jiangdi autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT qiucuipeng autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT dailiping autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT shijianxiang autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT wangkaijuan autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT songchunhua autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT wangpeng autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma
AT zhangjianying autoantibodiesagainsttumorassociatedantigenscombinedwithmicrornasindetectingesophagealsquamouscellcarcinoma